Immunomodulators Global Market Likely to Exhibit Substantial Growth at a CAGR of ~5% by 2028 | DelveInsight
19 juin 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, June 19, 2023 (GLOBE NEWSWIRE) -- Immunomodulators Global Market Likely to Exhibit Substantial Growth at a CAGR of ~5% by 2028 | DelveInsight The immunomodulators market is...
Immunomodulators Market Size worth US$ 304.37 billion by 2030 to grow at a CAGR of 5.3%| Growth Plus Reports
16 nov. 2022 02h56 HE
|
Growth Plus Reports
Pune, Nov. 16, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Immunomodulators Market will clock US$ 304.37 billion by 2030. The rapidly...
Immunomodulators Market to Expand at CAGR of 5.15% During 2022-2028 | Heavy Investment In R&D Activities and Focus on Launching New Drugs Will Offer Potential Opportunities for The Market Growth, Says The Brainy Insights
16 mai 2022 06h49 HE
|
The Brainy Insights
Newark, May 16, 2022 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global immunomodulators market is expected to grow from USD 171.05 billion in 2020 to USD 255.67...
Immunomodulators Market to Surpass US$ 156378.2 Million by 2028; Increasing prevalence of autoimmune disorders to bolster market growth, Says Coherent Market Insights (CMI)
07 oct. 2021 09h00 HE
|
CMI
SEATTLE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global immunomodulators market is estimated to be valued at US$ 91850.0 Million in 2021 and is expected to...
Immunomodulators Market worth USD 285.01 Billion at 6.3% CAGR; Enhancement of Supply Chain to Boost Growth amid COVID-19, reports Fortune Business Insights™
25 janv. 2021 06h46 HE
|
Fortune Business Insights
Pune, India, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The global immunomodulators market is set to gain momentum from the increasing research activities to introduce unique approaches to treat cancer...
Immunomodulators Market To Reach USD 239.7 Billion By 2026 | Reports And Data
13 nov. 2019 14h55 HE
|
Reports and Data
New York, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Production of advanced drugs, increasing adoption of monoclonal antibodies, and clinical urgency to develop new generation immunomodulators are key...